November 13, 2024 | 10:30 am – 02:00 pm (EST)
Cambridge

Join us for the biocrates-allumiqs biopharma day, a unique on-site event focused on the power of multi-omics research in pharmaceutical R&D. Leading experts will share real-world examples of how their companies are leveraging metabolomics and other omics approaches to improve biomarker and drug discovery pipelines. With high attrition rates posing a major challenge in pharmaceutical development, metabolomics offers valuable insights at every stage—from identifying novel therapeutic targets to optimizing drug safety and efficacy in clinical trials. Don’t miss this opportunity to explore how cutting-edge metabolomics research is shaping the future of drug development and engage with industry leaders in thoughtful discussions. We look forward to your participation!

Program overview

Introduction – 10:30 am EST

Speakers | Agenda

Non-regulated bioanalytical and biomarker quantitation at Cerevel/Abbvie’s ACX site

Metabolic predictors of outcomes in people with multiple sclerosis

ML-driven multi-omics analysis of platelet-rich plasma: Differentiating age-related biomarkers in young and old individuals

Lunch

12:00-01:00 pm EST

Case Study: Impact of Treatment Paradigms on Observed Pharmacology in Drug Discovery

Unbiased lipido |metabolomics and investigative drug metabolism sciences: An integrated approach assessing ADMET risks in drug discovery